Compound Explorer

All 296 entries in our encyclopedia in one table, filterable by evidence grade, FDA status, molecule class, half-life, route and WADA status. Every cell comes from the same dataset the entry pages are built from; open an entry for its sources. Grades follow our methodology, and the WADA column reads the 2026 Prohibited List as recorded in each entry. Nothing here is a recommendation, and nothing is sold or linked.

296 of 296 entries

Compound	Class	Category	FDA status	Evidence	Half-life	Route	WADA 2026
5-Amino-1MQ	Small molecule, not a peptide	Metabolic	Research Chemical	Low	Undetermined in humans	Oral	Prohibited (S0 catch-all)
Abarelix	Peptide	Sexual Health	Withdrawn	High	≈ 13 days	Injection	Unsettled (S0 may apply)
ACE-031	Protein, not a peptide	Research	Discontinued	Medium	Fc-mediated, typically 1–3 weeks in humans	Injection	Prohibited at all times (S4.3)
Acetyl Hexapeptide-30	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Acetyl Hexapeptide-37	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Acetyl Octapeptide-3	Peptide	Cosmetic	Dietary Supplement	Low	Hours (topical)	Topical or eye	Unsettled (S0 may apply)
Acetyl Tetrapeptide-2	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Acetyl Tetrapeptide-5	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Adamax	Peptide	Cognitive	Research Chemical	Low	Undetermined in humans	Injection, Nasal	Prohibited (S0 catch-all)
Adipotide	Peptide	Research	Preclinical	Low	Preclinical; not characterized in humans	Injection	Prohibited (S0 catch-all)
Adrenomedullin	Peptide	Cardiovascular	Research Chemical	Medium	≈ 22 minutes	Not stated	Prohibited (S0 catch-all)
Afamelanotide	Peptide	Sexual Health	FDA Approved	High	≈ 30 minutes	Not stated	Not on the 2026 List
AHK-Cu	Peptide	Cosmetic	Research Chemical	Low	Undetermined	Topical or eye	Prohibited (S0 catch-all)
Albiglutide	Protein, not a peptide	Metabolic	Discontinued	High	≈ 5 days	Injection	Prohibited (S0 catch-all)
Alpha-MSH	Peptide	Immune	Research Chemical	High	≈ 20 minutes	Not stated	Prohibited (S0 catch-all)
Alprostadil	Small molecule, not a peptide	Sexual Health	FDA Approved	High	Very short (< 1 minute in plasma)	Injection	Not on the 2026 List
Amycretin	Peptide	Pipeline & In-Development	In Clinical Trials	Medium	Suitable for weekly SC / daily oral	Injection, Oral	Prohibited (S0 catch-all)
Amylin	Peptide	Metabolic	Research Chemical	High	≈ 13 minutes	Not stated	Prohibited (S0 catch-all)
Anamorelin	Small molecule, not a peptide	Growth Hormone	Not FDA Approved	High	≈ 7 hours	Oral	Prohibited at all times (S2.2.4)
Angiotensin II	Peptide	Cardiovascular	FDA Approved	High	≈ 1 minute	Injection	Not on the 2026 List
ANP	Peptide	Cardiovascular	Research Chemical	High	≈ 3 minutes	Not stated	Unsettled (S0 may apply)
AOD-9604 Full entry	Peptide	Metabolic	Research Chemical	Medium	Not published for people	Injection	Prohibited at all times (S2.2.3)
Apelin	Peptide	Cardiovascular	Research Chemical	Medium	≈ 5 minutes	Not stated	Prohibited (S0 catch-all)
Apitegromab	Antibody, not a peptide	Pipeline & In-Development	In Development	High	Fc-mediated; weeks	Injection	Prohibited at all times (S4.3)
Apraglutide	Peptide	Pipeline & In-Development	In Development	High	~27 hours	Injection	Prohibited (S0 catch-all)
ARA-290	Peptide	Healing & Recovery	In Clinical Trials	Medium	~2 minutes (plasma)	Injection	Prohibited at all times (S2.1.5)
Argireline	Peptide	Cosmetic	Research Chemical	Medium	Topical only	Topical or eye	Unsettled (S0 may apply)
Atosiban	Peptide	Sexual Health	Not FDA Approved	High	≈ 18 minutes	Injection	Unsettled (S0 may apply)
AZD6234	Peptide	Pipeline & In-Development	In Clinical Trials	Low	Supports weekly dosing	Injection	Prohibited (S0 catch-all)
Bacitracin	Blend or mixture	Immune	FDA Approved	High	Topical; systemic use obsolete	Topical or eye	Not on the 2026 List
Beinaglutide	Peptide	Metabolic	Not FDA Approved	Medium	~11 minutes	Injection	Unsettled (S0 may apply)
Beta-Endorphin	Peptide	Cognitive	Research Chemical	High	≈ 20 minutes	Not stated	Prohibited (S0 catch-all)
Bimagrumab	Antibody, not a peptide	Pipeline & In-Development	In Clinical Trials	Medium	Fc-mediated; weeks	Injection	Prohibited at all times (S4.3)
Bioactive Food Peptides	Peptide	Research	Dietary Supplement	Medium	Variable — dipeptides and tripeptides absorbed intact via PepT1; larger peptides degraded	Oral	Not on the 2026 List
Biotinoyl Tripeptide-1	Peptide	Cosmetic	Dietary Supplement	Low	Hours (topical)	Topical or eye	Unsettled (S0 may apply)
Bivalirudin Full entry	Peptide	Cardiovascular	FDA Approved	High	≈ 25 minutes	Injection	Not on the 2026 List
BNP	Peptide	Cardiovascular	FDA Approved	High	≈ 20 minutes	Not stated	Not on the 2026 List
Botulinum Toxin	Protein, not a peptide	Cosmetic	FDA Approved	High	Clinical effect lasts 3–6 months per injection	Injection	Not on the 2026 List
BPC-157 Full entry	Peptide	Healing & Recovery	Research Chemical	Low	Short systemic half-life (minutes) but prolonged tissue effect	Injection, Oral	Prohibited at all times (S0)
Bradykinin	Peptide	Cardiovascular	Research Chemical	High	≈ 0.5 minutes	Not stated	Prohibited (S0 catch-all)
BRN2 (POU3F2) Research Peptide	Peptide	Cognitive	Research Chemical	Low	Not characterized	Not stated	Prohibited (S0 catch-all)
Bronchogen	Peptide	Longevity	Research Chemical	Low	Undetermined	Oral, Nasal	Prohibited (S0 catch-all)
Buserelin	Peptide	Sexual Health	Not FDA Approved	High	≈ 80 minutes	Injection, Nasal	Prohibited in males, at all times (S2.2.1)
Cagrilintide	Peptide	Metabolic	In Clinical Trials	Medium	≈ 7 days	Injection	Prohibited (S0 catch-all)
CagriSema Full entry	Blend or mixture	Pipeline & In-Development	In Development	High	Semaglutide ~165 hours; cagrilintide ~170 hours	Injection	Prohibited (S0 catch-all)
Calcitonin	Peptide	Healing & Recovery	FDA Approved	High	≈ 60 minutes	Injection, Nasal	Not on the 2026 List
Capromorelin	Small molecule, not a peptide	Growth Hormone	Discontinued	High	≈ 2 hours	Not stated	Prohibited at all times (S2.2.4)
Carbetocin	Peptide	Sexual Health	Not FDA Approved	High	≈ 40 minutes	Injection	Unsettled (S0 may apply)
Cardiogen	Peptide	Longevity	Research Chemical	Low	Undetermined	Injection, Oral	Prohibited (S0 catch-all)
Carnosine	Peptide	Longevity	Dietary Supplement	Medium	Rapidly hydrolyzed in plasma by serum carnosinase (CN1); tissue half-life much longer	Oral	Not on the 2026 List
Carperitide	Peptide	Cardiovascular	Not FDA Approved	Medium	≈ 3 minutes	Injection	Unsettled (S0 may apply)
Cartalax	Peptide	Longevity	Research Chemical	Low	Undetermined	Oral	Prohibited (S0 catch-all)
Cathelicidin	Protein, not a peptide	Immune	Research Chemical	High	LL-37: minutes in serum; longer at mucosal surfaces	Not stated	Prohibited (S0 catch-all)
Cecropin	Peptide	Immune	Research Chemical	Medium	Minutes in serum	Not stated	Prohibited (S0 catch-all)
Cerebrolysin Full entry	Blend or mixture	Cognitive	Not FDA Approved	High	Varies by component	Injection	Unsettled (S0 may apply)
Cerluten	Peptide	Longevity	Not FDA Approved	Low	Not characterized	Oral	Prohibited (S0 catch-all)
Cetrorelix	Peptide	Sexual Health	FDA Approved	High	≈ 30 hours	Injection	Not on the 2026 List
CGRP	Peptide	Cardiovascular	Research Chemical	High	≈ 7 minutes	Not stated	Prohibited (S0 catch-all)
Cholecystokinin	Peptide	Metabolic	Research Chemical	High	≈ 3 minutes	Not stated	Unsettled (S0 may apply)
Chonluten	Peptide	Longevity	Research Chemical	Low	Undetermined	Oral, Nasal	Prohibited (S0 catch-all)
CJC-1295 Full entry	Peptide	Growth Hormone	Discontinued	Medium	5.8–8.1 days (with DAC)	Injection	Prohibited at all times (S2.2.4)
CNP	Peptide	Cardiovascular	Research Chemical	High	≈ 3 minutes	Not stated	Prohibited (S0 catch-all)
Colistin	Peptide	Immune	FDA Approved	High	≈ 3 hours	Injection, Inhaled	Not on the 2026 List
Collagen Peptides	Blend or mixture	Cosmetic	Dietary Supplement	Medium	Variable — dipeptide Pro-Hyp detectable in plasma within 1 hour, peak ~2 hours	Oral	Not on the 2026 List
Colostrinin	Peptide	Cognitive	Dietary Supplement	Low	Unknown	Oral	Not on the 2026 List
Corifollitropin alfa	Protein, not a peptide	Sexual Health	Not FDA Approved	High	≈ 69 hours	Injection	Unsettled (S0 may apply)
Cortagen	Peptide	Longevity	Research Chemical	Low	Undetermined	Injection	Prohibited (S0 catch-all)
Cortexin	Blend or mixture	Cognitive	Not FDA Approved	Low	Not characterized	Injection	Unsettled (S0 may apply)
Corticorelin	Peptide	Growth Hormone	FDA Approved	High	Short (minutes)	Injection	Prohibited at all times (S2.2.2)
Cotadutide	Peptide	Pipeline & In-Development	Discontinued	Medium	≈ 9 hours	Injection	Prohibited (S0 catch-all)
Danuglipron	Small molecule, not a peptide	Pipeline & In-Development	Discontinued	Medium	Short; required BID or once-daily formulation work	Oral	Prohibited (S0 catch-all)
Daptomycin	Peptide	Immune	FDA Approved	High	≈ 8 hours	Injection	Not on the 2026 List
Davunetide	Peptide	Cognitive	In Clinical Trials	Medium	Short plasma half-life; intranasal dosing used to increase CNS exposure	Nasal	Prohibited (S0 catch-all)
Decorinyl	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Degarelix Full entry	Peptide	Sexual Health	FDA Approved	High	≈ 53 days	Injection	Not on the 2026 List
Dermcidin	Peptide	Immune	Research Chemical	Medium	Hours on skin surface	Not stated	Prohibited (S0 catch-all)
Dermorphin	Peptide	Research	Research Chemical	Low	Limited human PK	Not stated	Not on the 2026 List
Desmopressin	Peptide	Cardiovascular	FDA Approved	High	≈ 2.5 hours	Injection, Oral, Nasal	Prohibited at all times (S5)
Dihexa Full entry	Peptidomimetic	Cognitive	Research Chemical	Low	Undetermined in humans	Oral	Prohibited (S0 catch-all)
DSIP Full entry	Peptide	Cognitive	Research Chemical	Low	≈ 7 minutes	Injection	Prohibited (S0 catch-all)
Dulaglutide Full entry	Protein, not a peptide	Metabolic	FDA Approved	High	≈ 5 days	Injection	Not on the 2026 List
Dynorphin	Peptide	Cognitive	Research Chemical	High	≈ 5 minutes	Not stated	Prohibited (S0 catch-all)
ECC5004	Peptide	Pipeline & In-Development	In Clinical Trials	Low	Supports once-daily oral dosing	Oral	Prohibited (S0 catch-all)
Ecnoglutide	Peptide	Metabolic	Not FDA Approved	High	Supports once-weekly dosing	Injection	Unsettled (S0 may apply)
Efpeglenatide	Peptide conjugate	Pipeline & In-Development	In Clinical Trials	High	≈ 158 hours	Injection	Prohibited (S0 catch-all)
Eftansomatropin alfa	Protein, not a peptide	Pipeline & In-Development	Not FDA Approved	Medium	≈ 70 hours	Injection	Prohibited at all times (S2.2.3)
Elagolix	Small molecule, not a peptide	Sexual Health	FDA Approved	High	≈ 6 hours	Oral	Not on the 2026 List
Elsiglutide	Peptide	Pipeline & In-Development	Discontinued	Low	Phase 2 PK only	Injection	Prohibited (S0 catch-all)
Endoluten	Peptide	Longevity	Not FDA Approved	Low	Not characterized	Oral	Prohibited (S0 catch-all)
Endothelin-1	Peptide	Cardiovascular	Research Chemical	High	≈ 7 minutes	Not stated	Prohibited (S0 catch-all)
Enkephalin	Peptide	Cognitive	Research Chemical	High	≈ 2 minutes	Not stated	Prohibited (S0 catch-all)
Epithalon Full entry	Peptide	Longevity	Research Chemical	Low	Not characterised in humans	Injection	Prohibited (S0 catch-all)
Eptifibatide	Peptide	Cardiovascular	FDA Approved	High	≈ 2.5 hours	Injection	Not on the 2026 List
Erythropoietin (EPO)	Protein, not a peptide	Cardiovascular	FDA Approved	High	4–13 hours (epoetin alfa, IV) / 24 hours (SC) / up to 74 hours (darbepoetin)	Injection	Prohibited at all times (S2.1.1)
Examorelin	Peptide	Research	Research Chemical	Medium	Not measured in humans	Not stated	Prohibited at all times (S2.2.4)
Exenatide Full entry	Peptide	Metabolic	FDA Approved	High	≈ 2.4 hours	Injection	Not on the 2026 List
Felypressin	Peptide	Cardiovascular	Not FDA Approved	Medium	Short; local activity	Injection	Prohibited at all times (S5)
FGL Peptide	Peptide	Cognitive	Research Chemical	Low	Not characterized in humans	Not stated	Prohibited (S0 catch-all)
FK-13	Peptide	Healing & Recovery	Research Chemical	Medium	Not formally characterized in vivo	Not stated	Prohibited (S0 catch-all)
Follistatin-315	Protein, not a peptide	Research	Preclinical	Low	Minutes (circulating); tissue-bound component is long-lived	Injection	Prohibited at all times (S4.3)
Follistatin-344	Protein, not a peptide	Research	Preclinical	Low	Protein; tissue-bound	Injection	Prohibited at all times (S4.3)
Follitropin alfa Full entry	Protein, not a peptide	Sexual Health	FDA Approved	High	≈ 42.6 hours	Injection	Not on the 2026 List
Follitropin beta	Protein, not a peptide	Sexual Health	FDA Approved	High	≈ 40 hours	Injection	Not on the 2026 List
Follitropin delta	Protein, not a peptide	Sexual Health	Not FDA Approved	High	≈ 40 hours	Injection	Unsettled (S0 may apply)
FOXO4-DRI	Peptide	Longevity	Preclinical	Low	Undetermined in humans	Not stated	Prohibited (S0 catch-all)
Galanin	Peptide	Cognitive	Research Chemical	Medium	≈ 6 minutes	Not stated	Prohibited (S0 catch-all)
Ganirelix	Peptide	Sexual Health	FDA Approved	High	≈ 13 hours	Injection	Not on the 2026 List
Garetosmab	Antibody, not a peptide	Pipeline & In-Development	In Clinical Trials	Medium	Fc-mediated; weeks	Injection	Prohibited at all times (S4.3)
GDF11	Protein, not a peptide	Longevity	Research Chemical	Low	Not formally characterized pharmacokinetically	Not stated	Prohibited (S0 catch-all)
GDF15	Protein, not a peptide	Longevity	In Clinical Trials	High	Endogenous GDF15 has a plasma half-life of ~3 hours; engineered long-acting analogs in clinical development have half-lives supporting weekly or longer dosing intervals.	Not stated	Prohibited (S0 catch-all)
GHK-Cu Full entry	Peptide	Healing & Recovery	Research Chemical	Low	Undetermined (systemic)	Injection, Topical or eye	Prohibited (S0 catch-all)
Ghrelin	Peptide	Growth Hormone	Research Chemical	High	≈ 30 minutes	Injection	Prohibited at all times (S2.2.4)
GHRP-2 Full entry	Peptide	Growth Hormone	Not FDA Approved	Medium	Not reported in humans in the abstracts we hold	Injection	Prohibited at all times (S2.2.4)
GHRP-6 Full entry	Peptide	Growth Hormone	Research Chemical	Medium	≈ 2.5 hours	Injection	Prohibited at all times (S2.2.4)
GIP	Peptide	Metabolic	Research Chemical	High	≈ 7 minutes	Injection	Prohibited (S0 catch-all)
Glatiramer Acetate	Not a peptide	Immune	FDA Approved	High	Rapidly degraded at injection site	Injection	Not on the 2026 List
Glepaglutide	Peptide	Pipeline & In-Development	In Clinical Trials	Medium	Supports twice-weekly dosing	Injection	Prohibited (S0 catch-all)
GLP-2	Peptide	Metabolic	Research Chemical	High	≈ 7 minutes	Injection	Prohibited (S0 catch-all)
Glucagon	Peptide	Metabolic	FDA Approved	High	≈ 3 minutes	Injection, Nasal	Not on the 2026 List
Glutathione	Peptide	Longevity	Research Chemical	Low	Short plasma half-life (minutes to hours)	Injection	Unsettled (S0 may apply)
GMA106	Peptide	Pipeline & In-Development	In Clinical Trials	Low	Supports weekly dosing	Injection	Prohibited (S0 catch-all)
Gonadorelin Full entry	Peptide	Sexual Health	Discontinued	Medium	≈ 5 minutes	Injection	Prohibited in males, at all times (S2.2.1)
Goserelin Full entry	Peptide	Sexual Health	FDA Approved	High	≈ 4.2 hours	Injection	Prohibited in males, at all times (S2.2.1)
Gramicidin	Peptide	Immune	FDA Approved	High	Topical only	Topical or eye	Not on the 2026 List
hBD-1	Peptide	Immune	Research Chemical	Low	Not applicable — endogenous epithelial peptide	Not stated	Prohibited (S0 catch-all)
hBD-2	Peptide	Immune	Research Chemical	Low	Not applicable — endogenous epithelial peptide	Not stated	Prohibited (S0 catch-all)
hBD-3	Peptide	Immune	Research Chemical	Low	Not applicable — endogenous epithelial peptide	Not stated	Prohibited (S0 catch-all)
HCG Full entry	Protein, not a peptide	Growth Hormone	FDA Approved	High	≈ 29 hours	Injection	Prohibited in males, at all times (S2.2.1)
HD5	Peptide	Immune	Research Chemical	Low	Not applicable — endogenous epithelial peptide	Not stated	Prohibited (S0 catch-all)
HD6	Peptide	Immune	Research Chemical	Low	Not applicable — endogenous epithelial peptide	Not stated	Prohibited (S0 catch-all)
Hexarelin Full entry	Peptide	Growth Hormone	Research Chemical	Medium	Not measured in humans	Injection	Prohibited at all times (S2.2.4)
HGH Fragment 176-191	Peptide	Research	Research Chemical	Low	<30 minutes plasma	Injection	Prohibited at all times (S2.2.3)
Histatin	Peptide	Healing & Recovery	Research Chemical	Medium	≈ 10 minutes	Not stated	Prohibited (S0 catch-all)
Histrelin	Peptide	Sexual Health	FDA Approved	High	≈ 4 hours	Injection	Prohibited in males, at all times (S2.2.1)
HM15136	Peptide conjugate	Pipeline & In-Development	In Clinical Trials	Low	Supports weekly dosing	Injection	Prohibited (S0 catch-all)
HM15275	Peptide	Pipeline & In-Development	In Clinical Trials	Low	LAPSCOVERY-extended	Injection	Prohibited (S0 catch-all)
HNP-1	Peptide	Immune	Research Chemical	Low	Not applicable — endogenous granule-stored peptide	Not stated	Prohibited (S0 catch-all)
HNP-2	Peptide	Immune	Research Chemical	Low	Not applicable — endogenous granule-stored peptide	Not stated	Prohibited (S0 catch-all)
HNP-3	Peptide	Immune	Research Chemical	Low	Not applicable — endogenous granule-stored peptide	Not stated	Prohibited (S0 catch-all)
HRS-9531	Peptide	Pipeline & In-Development	In Clinical Trials	Medium	~6–8 days (supports weekly dosing)	Injection	Prohibited (S0 catch-all)
Humanin Full entry	Peptide	Longevity	Research Chemical	Low	Not measured in the abstracts we hold	Injection	Prohibited (S0 catch-all)
Hyaluronic Acid	Not a peptide	Cosmetic	FDA Approved	High	Dermal: up to 12 months (cross-linked); intra-articular: 17 hours to 1.5 days	Injection, Topical or eye	Not on the 2026 List
Icatibant	Peptide	Cardiovascular	FDA Approved	High	≈ 2 hours	Injection	Not on the 2026 List
IGF-1	Peptide	Growth Hormone	FDA Approved	High	≈ 12 hours	Injection	Prohibited at all times (S2.3)
IGF-1 DES(1-3)	Peptide	Research	Research Chemical	Low	Minutes to low hours	Injection	Prohibited at all times (S2.3)
IGF-1 LR3 Full entry	Protein, not a peptide	Research	Research Chemical	Low	Not measured in people; rats clear it faster than IGF-1	Injection	Prohibited at all times (S2.3)
Insulin aspart	Protein, not a peptide	Metabolic	FDA Approved	High	~1.5 hours	Injection	Prohibited at all times (S4.4.2)
Insulin degludec	Peptide	Metabolic	FDA Approved	High	≈ 25 hours	Injection	Prohibited at all times (S4.4.2)
Insulin degludec / liraglutide (IDegLira)	Peptide	Metabolic	FDA Approved	High	~25 h (degludec) / ~13 h (liraglutide)	Injection	Prohibited at all times (S4.4.2)
Insulin detemir	Peptide	Metabolic	Discontinued	High	~5–7 hours (plasma); 16–24 h clinical effect	Injection	Prohibited at all times (S4.4.2)
Insulin efsitora alfa	Protein, not a peptide	Pipeline & In-Development	In Development	High	≈ 408 hours	Injection	Prohibited at all times (S4.4.2)
Insulin glargine	Peptide	Metabolic	FDA Approved	High	~12 hours (effective)	Injection	Prohibited at all times (S4.4.2)
Insulin glargine / lixisenatide (iGlarLixi)	Peptide	Metabolic	FDA Approved	High	~12 h (glargine) / ~3 h (lixisenatide)	Injection	Prohibited at all times (S4.4.2)
Insulin glulisine	Protein, not a peptide	Metabolic	FDA Approved	High	~42 minutes	Injection	Prohibited at all times (S4.4.2)
Insulin icodec	Protein, not a peptide	Metabolic	Not FDA Approved	High	≈ 196 hours	Injection	Prohibited at all times (S4.4.2)
Insulin lispro	Protein, not a peptide	Metabolic	FDA Approved	High	~1 hour	Injection	Prohibited at all times (S4.4.2)
Ipamorelin Full entry	Peptide	Growth Hormone	Discontinued	Medium	≈ 2 hours	Injection	Prohibited at all times (S2.2.4)
Kisspeptin-10	Peptide	Sexual Health	In Clinical Trials	Medium	≈ 4 minutes	Injection	Prohibited in males, at all times (S2.2.1)
Kisspeptin-54	Peptide	Sexual Health	In Clinical Trials	Medium	≈ 28 minutes	Injection	Prohibited in males, at all times (S2.2.1)
Klotho Peptide	Protein, not a peptide	Longevity	Research Chemical	Medium	Hours (circulating soluble Klotho)	Not stated	Prohibited (S0 catch-all)
KN056	Peptide	Pipeline & In-Development	In Clinical Trials	Low	Long-acting design	Injection	Prohibited (S0 catch-all)
KPV Full entry	Peptide	Healing & Recovery	Research Chemical	Low	Not measured	Oral	Prohibited (S0 catch-all)
KR-12	Peptide	Healing & Recovery	Research Chemical	Medium	Minutes (proteolytic degradation)	Not stated	Prohibited (S0 catch-all)
Lactoferricin	Peptide	Immune	Research Chemical	Medium	Minutes in serum; active in gastrointestinal lumen	Not stated	Prohibited (S0 catch-all)
Langlenatide	Peptide conjugate	Pipeline & In-Development	Discontinued	Low	Undetermined	Injection	Prohibited (S0 catch-all)
Lanreotide	Peptide	Growth Hormone	FDA Approved	High	≈ 25 days	Injection	Not on the 2026 List
Larazotide	Peptide	Healing & Recovery	In Clinical Trials	Medium	≈ 1 hour	Oral	Prohibited (S0 catch-all)
Leuphasyl	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Leuprolide Full entry	Peptide	Sexual Health	FDA Approved	High	≈ 3 hours	Injection	Prohibited in males, at all times (S2.2.1)
Linaclotide	Peptide	Healing & Recovery	FDA Approved	High	Not systemically absorbed; acts luminally	Oral	Not on the 2026 List
Liraglutide Full entry	Peptide	Metabolic	FDA Approved	High	≈ 13 hours	Injection	Not on the 2026 List
Livagen	Peptide	Longevity	Research Chemical	Low	Undetermined	Oral	Prohibited (S0 catch-all)
Lixisenatide	Peptide	Metabolic	FDA Approved	High	≈ 3 hours	Injection	Not on the 2026 List
Lixivaptan	Peptide	Cardiovascular	In Clinical Trials	Medium	≈ 11 hours	Oral	Prohibited at all times (S5)
LL-37 Full entry	Peptide	Healing & Recovery	Research Chemical	Low	Undetermined	Injection, Topical or eye	Prohibited (S0 catch-all)
Lonapegsomatropin	Protein, not a peptide	Growth Hormone	FDA Approved	High	≈ 30 hours	Injection	Prohibited at all times (S2.2.3)
Lutetium-177 DOTATATE	Peptide conjugate	Research	FDA Approved	High	≈ 6.7 days	Injection	Not on the 2026 List
Lutropin alfa	Protein, not a peptide	Sexual Health	Discontinued	Medium	≈ 10 hours	Injection	Prohibited in males, at all times (S2.2.1)
Macimorelin	Small molecule, not a peptide	Growth Hormone	FDA Approved	High	≈ 4 hours	Oral	Prohibited at all times (S2.2.4)
Magainin	Peptide	Immune	Research Chemical	High	Minutes (in vivo)	Topical or eye	Prohibited (S0 catch-all)
Maridebart cafraglutide	Peptide conjugate	Pipeline & In-Development	In Clinical Trials	Medium	≈ 21 days	Injection	Prohibited (S0 catch-all)
Matrixyl	Peptide	Cosmetic	Research Chemical	Medium	Topical only	Topical or eye	Unsettled (S0 may apply)
Mazdutide	Peptide	Metabolic	Not FDA Approved	High	~8 days	Injection	Unsettled (S0 may apply)
Mecasermin	Peptide	Growth Hormone	FDA Approved	High	≈ 5.8 hours	Injection	Prohibited at all times (S2.3)
Mecasermin rinfabate	Protein, not a peptide	Growth Hormone	Discontinued	Medium	≈ 21 hours	Injection	Prohibited at all times (S2.3)
Melanotan II Full entry	Peptide	Sexual Health	Research Chemical	Low	≈ 1 hour	Injection	Prohibited (S0 catch-all)
Melatonin	Small molecule, not a peptide	Longevity	Dietary Supplement	Medium	20–50 minutes (immediate-release); several hours (sustained-release)	Oral, Topical or eye	Unsettled (S0 may apply)
Melittin	Peptide	Immune	Research Chemical	Medium	Minutes in serum	Not stated	Prohibited (S0 catch-all)
Menotropin	Protein, not a peptide	Sexual Health	FDA Approved	High	≈ 24 hours	Injection	Prohibited in males, at all times (S2.2.1)
MGF	Peptide	Research	Research Chemical	Low	~5–7 minutes (unmodified)	Not stated	Prohibited at all times (S2.3)
MK-677 Full entry	Small molecule, not a peptide	Growth Hormone	Discontinued	Medium	Not reported in the abstracts we hold	Oral	Prohibited at all times (S2.2.4)
Mod GRF 1-29	Peptide	Growth Hormone	Research Chemical	Low	≈ 30 minutes	Injection	Prohibited at all times (S2.2.4)
MOTS-c Full entry	Peptide	Longevity	Research Chemical	Low	Undetermined in humans	Injection	Prohibited at all times (S4.4.1)
NA-Selank Amidate	Peptide	Cognitive	Research Chemical	Low	Extended vs. native Selank (~minutes → estimated hours)	Nasal	Prohibited (S0 catch-all)
NAD+ Full entry	Small molecule, not a peptide	Longevity	Research Chemical	Medium	Not reported in the abstracts we hold	Injection	Unsettled (S0 may apply)
Nafarelin	Peptide	Sexual Health	FDA Approved	High	≈ 3 hours	Nasal	Prohibited in males, at all times (S2.2.1)
Navepegritide	Peptide conjugate	Growth Hormone	FDA Approved	High	≈ 95 hours	Injection	Not on the 2026 List
Nesiritide	Peptide	Cardiovascular	Discontinued	High	≈ 18 minutes	Injection	Unsettled (S0 may apply)
Neuropeptide Y	Peptide	Cognitive	Research Chemical	High	≈ 25 minutes	Not stated	Prohibited (S0 catch-all)
Neurotensin	Peptide	Cognitive	Research Chemical	Medium	≈ 3 minutes	Not stated	Prohibited (S0 catch-all)
Nisin	Peptide	Immune	Dietary Supplement	High	Stable at acidic pH; degraded at neutral/alkaline pH and by digestive proteases	Not stated	Not on the 2026 List
Noopept Full entry	Peptidomimetic	Cognitive	Not FDA Approved	Medium	≈ 30 minutes	Oral	Unsettled (S0 may apply)
NPAS3 Research Peptide	Peptide	Cognitive	Research Chemical	Low	Not characterized	Not stated	Prohibited (S0 catch-all)
NPH insulin (isophane)	Protein, not a peptide	Metabolic	FDA Approved	High	~4–6 hours	Injection	Prohibited at all times (S4.4.2)
Octreotide	Peptide	Growth Hormone	FDA Approved	High	≈ 100 minutes	Injection, Oral	Not on the 2026 List
Omiganan	Peptide	Healing & Recovery	Discontinued	High	Topical; minimal systemic exposure	Topical or eye	Prohibited (S0 catch-all)
Orexin-A	Peptide	Cognitive	Research Chemical	High	≈ 30 minutes	Not stated	Prohibited (S0 catch-all)
Orexin-B	Peptide	Cognitive	Research Chemical	High	≈ 5 minutes	Not stated	Prohibited (S0 catch-all)
Orforglipron Full entry	Small molecule, not a peptide	Metabolic	FDA Approved	Medium	≈ 39 hours	Oral	Not on the 2026 List
Ovagen	Peptide	Longevity	Research Chemical	Low	Undetermined	Oral	Prohibited (S0 catch-all)
Oxytocin	Peptide	Sexual Health	FDA Approved	High	~3–5 minutes (IV)	Nasal	Not on the 2026 List
P21	Peptidomimetic	Cognitive	Research Chemical	Low	Not established in human studies	Not stated	Prohibited (S0 catch-all)
Pal-GHK	Peptide	Cosmetic	Research Chemical	Medium	Topical only	Topical or eye	Unsettled (S0 may apply)
Palmitoyl Hexapeptide-12	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Palmitoyl Pentapeptide-4	Peptide	Cosmetic	Research Chemical	Medium	Topical only	Topical or eye	Unsettled (S0 may apply)
Palmitoyl Tetrapeptide-7	Peptide	Cosmetic	Dietary Supplement	Low	Hours (topical)	Topical or eye	Unsettled (S0 may apply)
Palmitoyl Tripeptide-38	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Palmitoyl Tripeptide-5	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Pasireotide	Peptide	Growth Hormone	FDA Approved	High	≈ 12 hours	Injection	Not on the 2026 List
PB-718	Peptide	Pipeline & In-Development	In Clinical Trials	Low	Supports weekly dosing	Injection	Prohibited (S0 catch-all)
PE-22-28	Peptide	Cognitive	Research Chemical	Low	Undetermined in humans	Not stated	Prohibited (S0 catch-all)
PEG-MGF	Peptide	Research	Research Chemical	Low	Native MGF ~5–7 minutes; PEG-MGF claimed hours (unverified in humans)	Injection	Prohibited at all times (S2.3)
Pegvisomant	Protein, not a peptide	Growth Hormone	FDA Approved	High	≈ 96 hours	Injection	Unsettled (S2.2.3 may apply)
Pemvidutide	Peptide	Pipeline & In-Development	In Clinical Trials	Medium	Supports once-weekly dosing	Injection	Prohibited (S0 catch-all)
Pentapeptide-3	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Peptide YY	Peptide	Metabolic	Research Chemical	High	≈ 12 minutes	Injection	Prohibited (S0 catch-all)
Petrelintide	Peptide	Pipeline & In-Development	In Clinical Trials	Medium	Engineered for once-weekly dosing	Injection	Prohibited (S0 catch-all)
Pexiganan	Peptide	Healing & Recovery	Discontinued	High	Topical; minimal systemic absorption	Topical or eye	Prohibited (S0 catch-all)
Pinealon	Peptide	Longevity	Research Chemical	Low	Undetermined	Oral	Prohibited (S0 catch-all)
Plecanatide	Peptide	Healing & Recovery	FDA Approved	High	Not systemically absorbed; acts luminally	Oral	Not on the 2026 List
PNC-27	Peptide	Research	Preclinical	Low	Undetermined	Not stated	Prohibited (S0 catch-all)
Polymyxin B	Peptide	Immune	FDA Approved	High	≈ 6 hours	Injection	Not on the 2026 List
Pralmorelin	Peptide	Growth Hormone	Not FDA Approved	High	Not reported in humans in the abstracts we hold	Injection	Prohibited at all times (S2.2.4)
Pramlintide	Peptide	Metabolic	FDA Approved	High	≈ 48 minutes	Injection	Not on the 2026 List
Prostamax	Peptide	Longevity	Not FDA Approved	Low	Not characterized in humans	Oral	Prohibited (S0 catch-all)
Protirelin	Peptide	Growth Hormone	Discontinued	High	≈ 5 minutes	Injection	Prohibited (S0 catch-all)
PT-141 Full entry	Peptide	Sexual Health	FDA Approved	High	≈ 2.7 hours	Injection	Not on the 2026 List
Regular human insulin	Protein, not a peptide	Metabolic	FDA Approved	High	~1.5 hours	Injection	Prohibited at all times (S4.4.2)
Relamorelin	Peptide	Pipeline & In-Development	In Clinical Trials	Medium	Short	Injection	Prohibited at all times (S2.2.4)
Relugolix	Small molecule, not a peptide	Sexual Health	FDA Approved	High	≈ 60 hours	Oral	Not on the 2026 List
Retatrutide Full entry	Peptide	Metabolic	In Clinical Trials	Medium	≈ 6 days	Injection	Prohibited (S0 catch-all)
Rigin	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Romiplostim	Protein, not a peptide	Immune	FDA Approved	High	≈ 3.5 days	Injection	Not on the 2026 List
Secretin	Peptide	Metabolic	FDA Approved	High	≈ 4 minutes	Not stated	Not on the 2026 List
Selank Full entry	Peptide	Cognitive	Not FDA Approved	Medium	≈ 10 minutes	Nasal	Unsettled (S0 may apply)
Semaglutide Full entry	Peptide	Metabolic	FDA Approved	High	≈ 7 days	Injection, Oral	Not on the 2026 List
Semax Full entry	Peptide	Cognitive	Not FDA Approved	Medium	≈ 30 minutes	Nasal	Unsettled (S0 may apply)
Sermorelin Full entry	Peptide	Growth Hormone	Discontinued	Medium	Not established in our sources	Injection	Prohibited at all times (S2.2.4)
Setmelanotide	Peptide	Metabolic	FDA Approved	High	≈ 11 hours	Injection	Not on the 2026 List
SHLP1	Peptide	Longevity	Research Chemical	Low	Undetermined	Not stated	Prohibited (S0 catch-all)
SHLP2	Peptide	Longevity	Research Chemical	Medium	Not formally characterized in humans	Not stated	Prohibited (S0 catch-all)
SHLP3	Peptide	Longevity	Research Chemical	Low	Not formally characterized	Not stated	Prohibited (S0 catch-all)
SHLP4	Peptide	Longevity	Research Chemical	Low	Undetermined	Not stated	Prohibited (S0 catch-all)
SHLP5	Peptide	Longevity	Research Chemical	Low	Undetermined	Not stated	Prohibited (S0 catch-all)
SHLP6	Peptide	Longevity	Research Chemical	Low	Not formally characterized	Not stated	Prohibited (S0 catch-all)
SNAP-8	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Somapacitan	Protein, not a peptide	Growth Hormone	FDA Approved	High	≈ 60 hours	Injection	Prohibited at all times (S2.2.3)
Somatostatin	Peptide	Growth Hormone	FDA Approved	High	≈ 2 minutes	Not stated	Not on the 2026 List
Somatrogon	Protein, not a peptide	Growth Hormone	FDA Approved	High	≈ 28 hours	Injection	Prohibited at all times (S2.2.3)
Somatropin (HGH) Full entry	Protein, not a peptide	Growth Hormone	FDA Approved	High	≈ 3.5 hours	Injection	Prohibited at all times (S2.2.3)
SS-31 (Elamipretide) Full entry	Peptide	Longevity	FDA Approved	High	≈ 4 hours	Injection	Not on the 2026 List
Substance P	Peptide	Immune	Research Chemical	High	Minutes (rapidly degraded by neutral endopeptidase/neprilysin and ACE)	Not stated	Prohibited (S0 catch-all)
Survodutide Full entry	Peptide	Metabolic	In Clinical Trials	High	Long enough for weekly dosing; not reported in the abstracts we hold	Injection	Prohibited (S0 catch-all)
Syn-Ake	Peptidomimetic	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Tabimorelin	Small molecule, not a peptide	Pipeline & In-Development	Discontinued	Low	Once-daily dosing feasible	Not stated	Prohibited at all times (S2.2.4)
Taldefgrobep alfa	Protein, not a peptide	Pipeline & In-Development	In Clinical Trials	Low	Days to weeks (Fc-mediated)	Injection	Prohibited at all times (S4.3)
Taspoglutide	Peptide	Pipeline & In-Development	Discontinued	High	~7 days (formulation-dependent)	Injection	Prohibited (S0 catch-all)
TB-500 Full entry	Peptide	Healing & Recovery	Research Chemical	Low	Undetermined in humans	Injection	Prohibited at all times (S2.3)
Teduglutide	Peptide	Metabolic	FDA Approved	High	≈ 2 hours	Injection	Not on the 2026 List
Teriparatide	Peptide	Healing & Recovery	FDA Approved	High	≈ 1 hour	Injection	Not on the 2026 List
Terlipressin	Peptide	Cardiovascular	FDA Approved	High	≈ 6 hours	Injection	Unsettled (S5 may apply)
Tesamorelin Full entry	Peptide	Growth Hormone	FDA Approved	High	8–11 minutes (current labels)	Injection	Prohibited at all times (S2.2.4)
Tesofensine Full entry	Small molecule, not a peptide	Research	In Clinical Trials	Medium	≈ 234 hours	Oral	Prohibited in competition (S6.B)
Testagen	Peptide	Longevity	Not FDA Approved	Low	Not characterized in humans	Oral	Prohibited (S0 catch-all)
Thymalin	Blend or mixture	Longevity	Not FDA Approved	Low	Not characterized as a mixture	Injection	Unsettled (S0 may apply)
Thymogen	Peptide	Longevity	Not FDA Approved	Low	Short plasma half-life consistent with dipeptide pharmacokinetics	Injection, Nasal	Unsettled (S0 may apply)
Thymopentin	Peptide	Immune	Not FDA Approved	Medium	≈ 30 seconds	Injection	Unsettled (S0 may apply)
Thymosin α1 Full entry	Peptide	Immune	Not FDA Approved	High	≈ 2 hours	Injection	Unsettled (S0 may apply)
Thymosin β4 Full entry	Peptide	Healing & Recovery	In Clinical Trials	Medium	Not reported in the abstracts we hold	Topical or eye	Prohibited at all times (S2.3)
Thymulin	Peptide	Immune	Research Chemical	Low	≈ 10 minutes	Injection	Prohibited (S0 catch-all)
Tirzepatide Full entry	Peptide	Metabolic	FDA Approved	High	≈ 5 days	Injection	Not on the 2026 List
Trevogrumab	Antibody, not a peptide	Pipeline & In-Development	In Clinical Trials	Low	Fc-mediated; weeks	Injection	Prohibited at all times (S4.3)
Tripeptide-10 Citrulline	Peptide	Cosmetic	Research Chemical	Low	Topical only	Topical or eye	Unsettled (S0 may apply)
Triptorelin	Peptide	Sexual Health	FDA Approved	High	≈ 3 hours	Injection	Prohibited in males, at all times (S2.2.1)
Ularitide	Peptide	Cardiovascular	Discontinued	High	≈ 13 minutes	Injection	Prohibited (S0 catch-all)
Urofollitropin	Protein, not a peptide	Sexual Health	FDA Approved	High	≈ 24 hours	Injection	Not on the 2026 List
Vancomycin	Peptide	Immune	FDA Approved	High	≈ 6 hours	Injection, Oral	Not on the 2026 List
Vasopressin Full entry	Peptide	Cardiovascular	FDA Approved	High	≈ 10 minutes	Injection	Unsettled (S5 may apply)
Ventfort	Peptide	Longevity	Not FDA Approved	Low	Not characterized in humans	Oral	Prohibited (S0 catch-all)
Vesugen	Peptide	Longevity	Research Chemical	Low	Short plasma half-life consistent with short-peptide pharmacokinetics; no human data	Not stated	Prohibited (S0 catch-all)
VIP	Peptide	Immune	In Clinical Trials	Medium	~2 minutes (IV)	Nasal, Inhaled	Unsettled (S0 may apply)
Visoluten	Peptide	Longevity	Not FDA Approved	Low	Not characterized	Oral	Prohibited (S0 catch-all)
VK2735	Peptide	Pipeline & In-Development	In Clinical Trials	Medium	Supports weekly SC dosing	Injection, Oral	Prohibited (S0 catch-all)
Vosoritide	Peptide	Growth Hormone	FDA Approved	High	≈ 30 minutes	Injection	Not on the 2026 List
Ziconotide	Peptide	Cognitive	FDA Approved	High	≈ 4.6 hours	Not stated	Not on the 2026 List
Zilucoplan	Peptide	Immune	FDA Approved	High	Supports once-daily SC dosing	Injection	Not on the 2026 List

How to read the columns

Class says whether an entry is a peptide at all. Proteins, antibodies, small molecules and blends are marked as not peptides, from each entry's own description.
FDA status is the US position only. "Not FDA Approved" can still mean approved elsewhere; the entry says where.
Evidence is our grade: high for replicated human trials or approval, medium for limited human data, low for animal or laboratory evidence only.
Half-life shows a measured or labelled value when the entry has one; hover or tap for the source note. "Not measured" is a finding, not a gap in the table.
Route is how the entry's studies or label give it, not a suggestion. An entry can have more than one.
WADA 2026 is the sport status in the List in force. "Prohibited under S0" means an unapproved substance caught by WADA's catch-all section rather than named.

The dataset behind this table is updated as entries are rewritten; each entry page carries its last-reviewed date.